ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,650.60
0.59%
S&P ASX All Technology
2,953.80
0.42%
Brent Oil
87.07
0.10%
US Dollar vs AUD
1.55008
-0.18%
Bitcoin
61,671.33
0.63%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) News

WINT Windtree Therapeutics Inc

0.3936
-0.0279 (-6.62%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0279 -6.62% 0.3936 09:38:48
Open Price Low Price High Price Close Price Previous Close
0.4188 0.3689 0.4188 0.401299 0.4215
more quote information »

Recent News

Date Time Source Heading
17/4/202422:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
09/4/202406:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
17/2/202409:07EDGAR2Form 8-K - Current report
15/2/202409:23EDGAR2Form S-3 - Registration statement under Securities Act of..
15/2/202408:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202408:40EDGAR2Form PRE 14A - Other preliminary proxy statements
02/2/202409:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202400:00GLOBEWindtree Renews Agreement with Chang Gung University for..
01/2/202400:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
01/2/202400:00EDGAR2Form 8-K - Current report
01/2/202400:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
26/1/202401:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
26/1/202400:34EDGAR2Form 8-K - Current report
26/1/202400:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
23/1/202408:45EDGAR2Form 8-K - Current report
18/1/202400:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
17/1/202423:56EDGAR2Form 8-K - Current report
17/1/202408:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202408:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
19/12/202300:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
17/11/202300:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
14/11/202303:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/11/202308:21EDGAR2Form 8-K - Current report
10/11/202308:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
10/11/202308:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202300:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
12/10/202322:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10/10/202322:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
03/10/202323:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
28/9/202321:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202321:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202322:48EDGAR2Form 8-K - Current report
21/9/202323:35GLOBEDawson James Securities Announces October Date for 8th..
06/9/202309:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202306:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202306:15EDGAR2Form 8-K - Current report
26/8/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202307:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
17/8/202307:19EDGAR2Form 8-K - Current report
08/8/202306:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
08/8/202306:02EDGAR2Form 8-K - Current report
08/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
WINT
Windtree Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved